It’s no exaggeration that calcium represents the Achilles heel of endovascular treatment. As the patient population continues to evolve in complexity we need solutions that can treat severe calcified disease in an efficacious, safe and durable way. Listen as Dr Konstantinos Stavroulakis shares the outcomes of his recent publication of Intravascular Lithotripsy (IVL) and DCB in severely calcified femoropopliteal lesions followed out to 12 months and understand why he believes IVL is a game changer in the treatment of complex real world patients.
Read More
Topics:
Peripheral IVL,
Peripheral Cases,
Peripheral Clinical Data
The presence of calcium can pose significant challenges in achieving optimal procedural outcomes in PAD treatment and can pose as a barrier to the delivery of large bore access devices. Shockwave IVL is shifting the paradigm in the way physicians approach calcium by simplifying procedures in an efficacious and safe manner. Now the next generation of peripheral IVL technology is here: Shockwave M5+! The Shockwave M5+ extends treatment options with the introduction of its new features; faster pulsing, an extended working length and expanded size matrix.
Read More
Topics:
Peripheral IVL,
Peripheral Cases,
Peripheral Clinical Data
Alternative access strategies in TAVI are prone to higher complication rates when compared to transfemoral access. This leads to the question; should physicians tackle difficult transfemoral over alternative access?
Read More
Topics:
Peripheral IVL,
Peripheral Cases,
Peripheral Conferences,
Peripheral Clinical Data
Great news! The Centers for Medicare and Medicaid Services (CMS) has increased payment for peripheral IVL procedures. The increases apply to procedures performed in anatomical locations above the knee in a hospital outpatient setting. The changes go into effect on January 1, 2022.
Read More
Topics:
Peripheral IVL,
Peripheral Cases,
Peripheral Clinical Data
Transfemoral access represents the gold standard for TAVI, with TF access showing a significant reduction in complications and mortality in comparison to alternative access strategies, which add additional complexity and risk to the procedure. Despite the wide acceptance that the transfemoral route provides the safest access for patients, the approach can be hindered by calcified iliac arteries inhibiting delivery of large bore devices by restricting the luminal diameter and reducing vessel compliance. If calcium is not treated adequately prior to TAVI delivery, this can lead to complications such as flow limiting dissection, vessel rupture and unsuccessful delivery of the implant.
Read More
Topics:
Peripheral IVL,
Peripheral Cases,
Peripheral Clinical Data
On Thursday, November 18, join us and six IVL experts at VEITH 2021 to hear how Intravascular Lithotripsy (IVL) works across multiple vessel beds.
Read More
Topics:
Peripheral IVL,
DISRUPT PAD,
Peripheral Cases,
Peripheral Conferences,
Peripheral Clinical Data
Calcium causes a magnitude of problems in EVAR and TEVAR procedures. Calcium can inhibit stent graft delivery leading to significant dissection or perforation of the iliac arteries. Calcium can also affect expansion of iliac limbs leading to increased risk of under expansion and stent graft thrombosis.
Watch as Dr. Stefano Fazzini, Tor Vergata University Hospital, Italy walks you through how Shockwave IVL can help alleviate access challenges while minimizing complications and the need for secondary interventions.
Read More
Topics:
Peripheral IVL,
DISRUPT PAD,
Peripheral Cases,
Peripheral Conferences,
Peripheral Clinical Data
We’ve all heard that Shockwave IVL doesn’t work in eccentric calcium… well that’s just a myth. Watch Prof. Andrew Holden’s presentation from CIRSE21 as he walks you through IVL’s eccentric vs concentric lesion data subset from the PADIII Observational Study and learn how this myth can well and truly be dispelled.
Read More
Topics:
Peripheral IVL,
DISRUPT PAD,
Peripheral Cases,
Peripheral Conferences,
Peripheral Clinical Data
Dr. Ehrin Armstrong presented the interim results from the first 752 patients in the Disrupt PAD III Observational Study (OS), reinforcing the consistency of IVL's unique mechanism of action to safely and effectively modify superficial and deep calcium across multiple vessel beds, lesion types and CLI patients.
Read More
Topics:
Peripheral IVL,
DISRUPT PAD,
Peripheral Cases,
Peripheral Conferences,
Peripheral Clinical Data
If you are attending VIVA21, you may not be dealing cards, but you’re likely dealing with peripheral artery calcium. So join Dr. Sahil Parikh, Dr. Ehrin Armstrong, Dr. Venita Chandra and Dr. Peter Soukas at 12pm Pacific Time on Wednesday, October 6th in the Bandol Room to make sure you don’t gamble with your calcium strategy. Listen to the esteemed panel during the Shockwave Medical Symposium and you learn how Intravascular Lithotripsy (IVL) can help you beat the odds.
Read More
Topics:
Peripheral IVL,
DISRUPT PAD,
Peripheral Cases,
Peripheral Conferences,
Peripheral Clinical Data
